ArticleDiagnostics (Basel, Switzerland)2026

Senicapoc in Patients with Idiopathic Pulmonary Fibrosis or Other Progressive Fibrotic Interstitial Lung Diseases: Protocol for a Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase II Trial.

Line Kølner-Augustson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.